- AdventHealth
ORLANDO, Fla., May 21, 2024 — AdventHealth and Heart of Florida United Way are teaming up to introduce the next phase of a first-of-its-kind movement to get Central Floridians talking about mental health with the new campaign “Lidera ConscienteMENTE.”
This campaign is an adaptation of the “Be a Mindleader” initiative, which, since launching a year ago, has helped children and parents become more comfortable discussing mental health and connected hundreds of families to counseling services.
The goal of transcreating the campaign into Spanish is to get curated, expert information designed specifically for a multicultural Hispanic audience directly into the hands of adults to encourage open conversations about mental health with children, family or friends.
This multicultural aspect of the “Be a Mindleader” campaign is particularly important, as research has found that one in every three Latinos says they struggle with mental health, yet only 5% are open to talking about it. And for those who suffer, it can take up to 11 years to get a diagnosis and seek treatment.
Talking about mental health is one of the best ways to reduce the stigma, create hope and lead people to seek care, according to the American Psychiatric Association.
“Hispanic populations face unique mental health challenges, such as immigration stress and cultural adaptation,” said Jeff Hayward, President and CEO of Heart of Florida United Way. “That's why Lidera ConscienteMENTE seeks to foster an environment of openness and trust, where expressing feelings, concerns and hopes is not only welcomed, but becomes the foundation for building a healthier and more resilient future for all.”
“The launch of the Spanish-language mental health campaign, in partnership with Heart of Florida United Way, signifies a substantial stride in destigmatizing mental health and promoting open dialogue about well-being in our community,” said Linnette Johnson, chief clinical operations officer for AdventHealth’s Central Florida Division. “By providing culturally sensitive resources, we proudly advance our mission to eradicate stigma and prioritize mental wellness for everyone in our diverse community. We are keeping our promise of providing whole-person care – body, mind and spirit – to the communities we serve.”
Launching this week, www.LideraConscienteMENTE.com can connect individuals to:
- Mental health hotlines and suicide and crisis prevention resources
- Tips and advice for starting conversations and handling difficult situations
- AdventHealth for Children’s Mental Health Navigation team that can help parents find resources and navigate the health care system
The "Be a Mindleader” campaign builds on a partnership between AdventHealth and Dr. Phillips Charities to establish Central Florida’s first comprehensive pediatric and adolescent mental and behavioral health program. Made possible with a $6 million grant from Dr. Phillips Charities, the growing program will expand access to pediatric mental health care, increase early diagnosis and intervention, help families navigate the complex mental and behavioral health care system, and reduce ER visits and hospitalizations for children. Recognizing there is a nationwide shortage of pediatric mental health providers and families often wait months to get into appointments, the program is designed so patients can get into counseling appointments in a matter of weeks, sometimes sooner.
The program — recognized as one of the “Top 36 Hospitals with a Great Mental Health Program” by Becker’s Hospital Review — continues to grow and in 2023 had nearly 950 patient visits.
Recent News
AdventHealth Cancer Institute Advances the Use of CAR T-Cell Therapy for Multiple Myeloma
CAR-T therapies have emerged as new treatment options for certain types of cancer through a one-time infusion that can lead to long-lasting remission.
AdventHealth Graduate Medical Education Program Celebrates 50 Years
Growing from a family practice residency to 24 accredited programs, AdventHealth’s Graduate Medical Education (GME) program celebrates 50 years.
New Clinical Trial Explores Digital Intervention for Apathy in Late-life Depression
Afflicting 30-50% of patients with late-life depression, apathy is a challenging psychiatric syndrome in older adulthood that can result in lack of motivation leading to poor self-care, physical...
AdventHealth Performs Central Florida’s First Liver Transplant for Unresectable Colorectal Liver Metastases
In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...
AdventHealth Neuroscience Institute First in Florida to be Recognized as a GammaTile Center of Excellence
GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was...
An AdventHealth Collaboration Explores the Impact of Microgravity and Electrical Stimulation on Muscle Cell Health in Space
Using a muscle lab-on-chip model aboard the International Space Station (ISS), AdventHealth Translational Research Institute’s Dr. Paul Coen has been working with a multidisciplinary team from the...
AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease
While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...
AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA)
Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy
Findings of the phase III, multicenter, randomized NSABP B-51-RTOG 1304 clinical trial were recently published in the New England Journal of Medicine with AdventHealth Cancer Institute’s Dr. Mamounas...
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease
Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...